InvestorsHub Logo
Followers 26
Posts 429
Boards Moderated 0
Alias Born 05/31/2015

Re: None

Saturday, 04/28/2018 7:42:13 PM

Saturday, April 28, 2018 7:42:13 PM

Post# of 689164
I wanted to make a few simple points because some of the posts about survival are so off.

5 year survival is not the same as the tail.
The tail is the benefit of immunotherapy
The classic example of that is Yervoy. It has a tail of about 10%.with melanoma. That is why it is approved. One of my specialties is operative managment of metastatic melanoma.
There is no tail in any approved treatment for glioblastoma period. No matter how many treatments someone gets(multiple surgeries or drugs) there is no tail. If you followed a hundred patients for a full 5 years 5-10% would be alive. Again that is different than 5 year survival on a KM curve. Neurosurgeons know that. My uncle is a neurosurgeon at Henry Ford Hospital and my best friend is a neurosurgeon at University of Washington. They can’t wait to see results. They believe in it.
If there is a blended tail above 20% this is gonna be a grandslam. I think once unblended the MOS of the treatment arm will be impressive anyways.
The publication is just a taste. It is with not fully mature data.
Wait until they hopefully update the blended data
If over 80 patients are alive, wow
I don’t really care what anyone else says. This is for people who know me. I never read this board anymore because of the ridiculous statements by a lot of people who are either lying or think they know what they are talking about when it comes to the science.
I am 100% confident we get approved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News